CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma

Abou-Alfa, G. K., Geyer, S. M., Nixon, A. B., Innocenti, F., Shi, Q., Kumthekar, P., Jacobson, S., El Dika, I., Yaqubie, A., Lopez, J., Huang, B., Tang, Y.-W., Wen, Y., Schwartz, L. H., El-Khoueiry, A. B., Knox, J. J., Rajdev, L., Bertagnolli, M. M., Meyerhardt, J. A., … Venook, A. P. (2024). CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Research Communications, 4(3), 682–690. https://doi.org/10.1158/2767-9764.crc-22-0516
Authors:
Ghassan K. Abou‐Alfa
Susan M. Geyer
Andrew B. Nixon
Federico Innocenti
Qian Shi
Priya Kumthekar
Sawyer Jacobson
Imane El Dika
Amin Yaqubie
Juan Lopez
Binhui Huang
Yi‐Wei Tang
Yujia Wen
Lawrence H. Schwartz
Anthony B. El-Khoueiry
Jennifer J. Knox
Lakshmi Rajdev
Monica M. Bertagnolli
Jeffrey A. Meyerhardt
Eileen M. O’Reilly
Alan P. Venook
Affiliated Authors:
Lawrence H. Schwartz
Publication Type:
Article
Unique ID:
10.1158/2767-9764.crc-22-0516
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: